Grow Your Pharma Business Digitally
Virtual Booth
Contact Supplier
Product Reset all filters
01 1Smyraf
Peficitinib Hydrobromide
Astellas
Main Therapeutic Indication : Immunology
Currency : USD
2022 Revenue in Millions : 18
2021 Revenue in Millions : 20
Growth (%) : -10
Portfolio PDF
Product Web Link
Digital Content
Website
Corporate PDF